Amedisys Inc financial data

Symbol
AMED on Nasdaq
Industry
Services-Home Health Care Services
Location
3854 American Way, Suite A, Baton Rouge, LA
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-K - Q4 2024 - Feb 27, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 117 % +14.2%
Debt-to-equity 84.2 % -2.27%
Return On Equity 3.68 %
Return On Assets 2.04 %
Operating Margin 4.03 % -42.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 32.8M shares +0.41%
Common Stock, Shares, Outstanding 32.8M shares +0.33%
Entity Public Float 3B USD +15.4%
Weighted Average Number of Shares Outstanding, Basic 32.7M shares +0.37%
Weighted Average Number of Shares Outstanding, Diluted 33.1M shares +1.39%

Income Statement

Label TTM Value / Value Unit Change %
Revenues 2.35B USD +5.01%
General and Administrative Expense 857M USD +4.9%
Costs and Expenses 2.25B USD +8.36%
Operating Income (Loss) 94.5M USD -39.6%
Nonoperating Income (Expense) -8.32M USD +92.9%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 86.2M USD +118%
Income Tax Expense (Benefit) 48.1M USD -4.96%
Net Income (Loss) Attributable to Parent 43.2M USD -205%
Earnings Per Share, Basic 1.32 USD/shares -209%
Earnings Per Share, Diluted 1.31 USD/shares -203%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 303M USD +140%
Accounts Receivable, after Allowance for Credit Loss, Current 296M USD -5.52%
Other Assets, Current 19.7M USD -34.5%
Assets, Current 632M USD +27.2%
Property, Plant and Equipment, Net 42.1M USD +0.63%
Operating Lease, Right-of-Use Asset 81.5M USD -8.36%
Intangible Assets, Net (Excluding Goodwill) 81.2M USD -21%
Goodwill 1.21B USD -2.47%
Other Assets, Noncurrent 88M USD +3.39%
Assets 2.14B USD +3.81%
Accounts Payable, Current 40M USD +41.5%
Employee-related Liabilities, Current 152M USD +11.1%
Accrued Liabilities, Current 153M USD +8.94%
Liabilities, Current 514M USD +8.59%
Long-term Debt and Lease Obligation 339M USD -6.23%
Deferred Income Tax Liabilities, Net 48.1M USD +18.3%
Operating Lease, Liability, Noncurrent 56.1M USD -10.6%
Other Liabilities, Noncurrent 882K USD -37.8%
Liabilities 959M USD +1.95%
Retained Earnings (Accumulated Deficit) 791M USD +5.78%
Stockholders' Equity Attributable to Parent 1.13B USD +6.38%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 1.18B USD +5.37%
Liabilities and Equity 2.14B USD +3.81%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.54M USD -125%
Net Cash Provided by (Used in) Financing Activities -8.55M USD +85%
Net Cash Provided by (Used in) Investing Activities -3.07M USD -107%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 38.3M shares +0.46%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 303M USD +118%
Interest Paid, Excluding Capitalized Interest, Operating Activities 8.19M USD +23.1%
Deferred Tax Assets, Valuation Allowance 5.2M USD -3.7%
Deferred Tax Assets, Gross 78M USD +2.09%
Operating Lease, Liability 82M USD -7.87%
Payments to Acquire Property, Plant, and Equipment 2.67M USD +97.8%
Lessee, Operating Lease, Liability, to be Paid 89.4M USD -7.65%
Property, Plant and Equipment, Gross 143M USD +6.56%
Operating Lease, Liability, Current 25.9M USD -1.43%
Lessee, Operating Lease, Liability, to be Paid, Year Two 25.8M USD -1.15%
Lessee, Operating Lease, Liability, to be Paid, Year One 29.2M USD -1.02%
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure +23.8%
Deferred Income Tax Expense (Benefit) 2.59M USD -6.42%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.4M USD -5.13%
Lessee, Operating Lease, Liability, to be Paid, Year Three 18.5M USD -6.09%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 0 USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 11.3M USD -14.4%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 6.14M USD +7.8%
Deferred Tax Assets, Net of Valuation Allowance 72.8M USD +2.54%
Interest Expense 32.3M USD +25.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%